TY - JOUR
T1 - Duplex microfluidic SERS detection of pathogen antigens with nanoyeast single-chain variable fragments
AU - Wang, Yuling
AU - Rauf, Sakandar
AU - Grewal, Yadveer S.
AU - Spadafora, Lauren J.
AU - Shiddiky, Muhammad J.A.
AU - Cangelosi, Gerard A.
AU - Schlücker, Sebastian
AU - Trau, Matt
N1 - Publisher Copyright:
© 2014 American Chemical Society.
PY - 2014/10/7
Y1 - 2014/10/7
N2 - Quantitative and accurate detection of multiple biomarkers would allow for the rapid diagnosis and treatment of diseases induced by pathogens. Monoclonal antibodies are standard affinity reagents applied for biomarkers detection; however, their production is expensive and labor-intensive. Herein, we report on newly developed nanoyeast single-chain variable fragments (NYscFv) as an attractive alternative to monoclonal antibodies, which offers the unique advantage of a cost-effective production, stability in solution, and target-specificity. By combination of surface-enhanced Raman scattering (SERS) microspectroscopy using glass-coated, highly purified SERS nanoparticle clusters as labels, with a microfluidic device comprising multiple channels, a robust platform for the sensitive duplex detection of pathogen antigens has been developed. Highly sensitive detection for individual Entamoeba histolytica antigen EHI115350 (limit of detection = 1 pg/mL, corresponding to 58.8 fM) and EHI182030 (10 pg/mL, corresponding 453 fM) with high specificity has been achieved, employing the newly developed corresponding NYscFv as probe in combination with SERS microspectroscopy at a single laser excitation wavelength. Our first report on SERS-based immunoassays using the novel NYscFv affinity reagent demonstrates the flexibility of NYscFv fragments as viable alternatives to monoclonal antibodies in a range of bioassay platforms and paves the way for further applications.
AB - Quantitative and accurate detection of multiple biomarkers would allow for the rapid diagnosis and treatment of diseases induced by pathogens. Monoclonal antibodies are standard affinity reagents applied for biomarkers detection; however, their production is expensive and labor-intensive. Herein, we report on newly developed nanoyeast single-chain variable fragments (NYscFv) as an attractive alternative to monoclonal antibodies, which offers the unique advantage of a cost-effective production, stability in solution, and target-specificity. By combination of surface-enhanced Raman scattering (SERS) microspectroscopy using glass-coated, highly purified SERS nanoparticle clusters as labels, with a microfluidic device comprising multiple channels, a robust platform for the sensitive duplex detection of pathogen antigens has been developed. Highly sensitive detection for individual Entamoeba histolytica antigen EHI115350 (limit of detection = 1 pg/mL, corresponding to 58.8 fM) and EHI182030 (10 pg/mL, corresponding 453 fM) with high specificity has been achieved, employing the newly developed corresponding NYscFv as probe in combination with SERS microspectroscopy at a single laser excitation wavelength. Our first report on SERS-based immunoassays using the novel NYscFv affinity reagent demonstrates the flexibility of NYscFv fragments as viable alternatives to monoclonal antibodies in a range of bioassay platforms and paves the way for further applications.
UR - http://www.scopus.com/inward/record.url?scp=84907903885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907903885&partnerID=8YFLogxK
U2 - 10.1021/ac5027012
DO - 10.1021/ac5027012
M3 - Article
AN - SCOPUS:84907903885
SN - 0003-2700
VL - 86
SP - 9930
EP - 9938
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 19
ER -